Similarly, a recent study showed that SLC22A3 expression in renal cell carcinoma cell lines also enhanced sensitivity to chemotherapeutics such as melphalan, irinotecan, and vincristine [27]. Here, SLC22A3 is linked to hereditary clear cell renal cell carcinoma.